OrthoPediatrics Corp. (FRA:2X7)

Market Cap	396.85M
Revenue (ttm)	193.82M
Net Income (ttm)	-38.88M
Shares Out	n/a
EPS (ttm)	-1.67
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	15.10
Previous Close	15.00
Day's Range	15.10 - 15.10
52-Week Range	13.40 - 26.20
Beta	n/a
RSI	53.93
Earnings Date	Mar 6, 2026

About OrthoPediatrics

OrthoPediatrics Corp., a medical device company, engages in designing, developing, and marketing anatomically appropriate implants, instruments, and specialized braces for children with orthopedic conditions in the United States and internationally. The company offers pediatric trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity in children; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc Tibia, ACL Reconstruct...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2006
• Employees: 562
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 2X7

Financial Performance

In 2024, OrthoPediatrics's revenue was $204.73 million, an increase of 37.65% compared to the previous year's $148.73 million. Losses were -$37.82 million, 80.3% more than in 2023.

Financial numbers in USD